ETH Zurich microbots can dissolve blood clots much faster than medicine alone. The university announced the work on Monday (09/11): the bots, made of a biocompatible gel with magnetic nanoparticles, are about eight micrometres long — less than one hundredth of a millimetre, roughly the size of a red blood cell — and have already been tested successfully in live pigs.
How the microbots work
The team is led by Simone Schürle, Professor of Medical Microsystems at ETH Zurich. The microbots are shaped like tiny cocoons, made of a sugar-polymer gel in which iron oxide nanoparticles are clustered along the longitudinal axis — that is what makes the bot react to a magnetic field like a compass needle.
The idea is to bring the microbots, together with the clot-dissolving medication, close to the thrombus with the help of a catheter. An external magnetic control system then generates a rotating field that makes the bots spin: they move along the vessel wall in a series of somersaults, like a gymnast doing one handspring after another. As they move, they pull and push the surrounding blood, creating small flows that carry the medicine to the clot — exactly the spot that stagnant blood cannot reach, because the thrombus itself blocks circulation.
Clot dissolves six times faster in the lab
In laboratory tests, the team used a silicon model with channels based on blood vessels and clots made from pig's blood. Aided by the moving microbots, the medication dissolved the clot six times faster than without them.
The next step was to test the method in live animals, together with scientists from Charité University Hospital in Berlin. After blocking the pigs' arteries with a clot, the researchers measured how much the rotating microbots increased the medicine's efficiency. After 30 minutes, the area of blood vessel to which blood flow had been restored was twice as large as with the medication alone. “To our knowledge, we are the first to show in a clinically relevant large-animal model that the use of microrobots in this way does indeed enhance thrombolysis, i.e. the process of dissolving blood clots”, Schürle said.
What is still needed before patients
The microbots have not yet been used in human patients. ETH Zurich has filed a patent application and nominated the invention for the Spark Award, the prize with which the university honours the most promising patent application of the year. The results have been recorded in a scientific paper that is undergoing peer review prior to publication. Before any use in people with acute vascular obstruction, the team wants to investigate the microbots' safety in animals over longer periods and test them in specific models, such as heart-attack models.
This project should not be confused with another microrobot from the same university, reported in 2025: in that study, a spherical capsule of soluble gel was magnetically guided to the thrombus. The current project is different — the cocoon-shaped microbots do not just carry the medicine, they generate the very flow that delivers it to the clot.
Image: inside of a blood vessel with a clot and blue microbots (ETH Zurich / Piyset / Adobe Stock).
Source: ETH Zurich — Dissolving blood clots with flow-generating microbots.
Transparency note: this article was produced with the assistance of artificial intelligence, cross-checking public posts on X and sources on the internet, and reviewed before publication. Check the original sources to confirm the information.
Por Muse